MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$196,612K
Cash and cash
equivalents
$40,102K
Prepaid and other
current assets
$3,189K
Accounts receivable
$43K
Total current assets
$239,946K
Investment in angel
pharmaceuticals
$10,496K
Other assets
$1,720K
Operating lease
right-of-use asset
$751K
Property and equipment,
net
$282K
Total assets
$253,195K
Total liabilities and
stockholders' equity
$253,195K
Total stockholders'
equity
$240,679K
Total liabilities
$12,516K
Accumulated deficit
-$425,985K
Accumulated other
comprehensive loss
-$1,126K
Additional paid-in capital
$667,782K
Total current
liabilities
$12,110K
Operating lease liability
$406K
Common stock 0.0001 par
value 290,000,000...
$8K
Accrued and other
liabilities
$6,985K
Accounts payable
$4,697K
Operating lease liability
$428K
Back
Back
Balance Sheet
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)
source: myfinsight.com